Academic Research Challenges for Modern Society (Paperback)

Jan Vrba is a Czech-born academic and innovation leader currently serving as a Senior Full Professor (Profesor Titular C) at Universidad Azteca. He holds a Ph.D. in Business Administration, a PhDr. in Political Science, and multiple Master’s degrees in Economics and Business Analytics. His extensive international career spans roles as Vice-Dean and Lecturer in Central Europe, Academic Expert in India, and Chief Innovation Officer in Malaysia. Prof. Vrba specializes in international partnership development and global research management within multicultural environments. He is an active contributor to the scholarly community as Deputy Editor-in-Chief for IJPAMED, Academic Editor for PLOS One, and Reviewer for Frontiers in Education & Frontiers in Psychology. A multilingual scholar fluent in Czech, Slovak, English, and Japanese, he has been honored with the “Distinguished Professor” and “Rector’s Award.” His current research focuses on the intersection of AI, Public Administration, and Higher Education & Learning.

Mohd Redzuan Mohd Sofian is an accomplished professional with a remarkable international career spanning 33 years in various industries, both private and public. He has developed diverse skill sets and gained valuable experience working with multinational Fortune 500 companies. He holds a Chemical Engineering Degree from Northwestern University in the USA, a Master's in Business Administration (MBA) from Birmingham University in the UK, and a Doctorate in Business Administration (DBA) from an American university in Los Angeles, California, USA. Throughout his career, he has held a range of significant positions in international organizations, involving diverse roles such as Project Engineer, Consultant, Manager of Retail, Senior Vice President, Business Development Director, Chief Operating Officer (COO), Executive Director (Board Member), Chairman of the Board, Chief Executive Officer (CEO), and International University Professor and Adjunct Professors. In addition to his extensive professional background, Mohd Redzuan is an active member of numerous international associations. Notable among these are the Chartered Management Institute (CMI) UK, the Association of International Certified Professional Accountants (AICPA & CIMA), the World Economics Association (WEA) UK, the American Management Association (AMA) USA, the American Society of Mechanical Engineers (ASME) USA, the American Planning Association (APA) USA, Association of Project Management (APA) UK, Chartered Management Institute (CMI) UK, American Institute of Chemical Engineers (AiCHE) USA, Australian Marketing Institute (AMI) AUSTRALIA, and the Institute of Risk Management (IRM), UK to name a few. Prof. Dr Redzuan holds editorial board member positions in esteemed academic journals like the International Journal of Business and Economic Research, the Journal of Management and Sustainability, the International Journal of Entrepreneurship and Small Business, the Journal of Applied Business Research, and the International Journal of Innovation and Technology Management. Furthermore, Mohd Redzuan has contributed significantly to his nation via his contribution to distinguished international organizations and initiatives during his tenure as the Chairman of the ASEAN COSTI (Committee of Science, Technology, and Innovation) subcommittee in biotechnology, Chairman of the Processing and Refining, Business Development Committee ASEAN Council on Petroleum (ASCOPE), Chairman of the ASEAN Plant Council, the Second Representative in the Investor Council of the Coalition for Epidemic Preparedness Innovation (CEPI) based in the United Kingdom, and a distinguished member of the Governing Council of the ASEAN Centre of Microbial Utilization. He has also taken a significant role in implementing the National Biotechnology Impact Study and the National Vaccine Development Roadmap while he was the CEO of the largest biotechnology research facility in the country, resulting in the establishment of the nation’s first Vaccine Development Research Centre during the Covid 19 pandemic.